KYORIN Pharmaceutical Co., Ltd. (TYO:4569)

KYORIN Pharmaceutical Revenue

KYORIN Pharmaceutical had revenue of 29.65B JPY in the quarter ending June 30, 2026, a decrease of -1.90%. This brings the company's total for the last twelve months to 125.68B, down -4.71% year-over-year. In the fiscal year ending March 31, 2026, KYORIN Pharmaceutical had annual revenue of 126.26B, down -2.94%. That makes KYORIN Pharmaceutical the 8,686th largest company in the world by revenue and 914th in Japan.

• Revenue (ttm): 125.68B
• Revenue Growth: -4.71%
• P/S Ratio: 0.51
• Revenue / Employee: 63.41M
• Employees: 1,982
• Market Cap: 64.63B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Japan 87.11B 69.0%
• Unallocated 38.45B 30.5%
• Overseas 693.00M 0.5%

Fiscal year ended Mar 31, 2026 See the full KYORIN Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	126.26B	-3.83B	-2.94%
Mar 31, 2025	130.09B	10.56B	8.83%
Mar 31, 2024	119.53B	6.26B	5.53%
Mar 31, 2023	113.27B	7.74B	7.33%
Mar 31, 2022	105.53B	2.63B	2.56%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error